Holen Sie sich die Stockscreener-App
74.84
0.32%
0.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$74.61
Offen:
$74.935
24-Stunden-Volumen:
893.11K
Relative Volume:
0.12
Marktkapitalisierung:
$94.93B
Einnahmen:
$386.46B
Nettoeinkommen (Verlust:
$4.49B
KGV:
20.91
EPS:
3.58
Netto-Cashflow:
$4.78B
1W Leistung:
-0.09%
1M Leistung:
+4.61%
6M Leistung:
+11.38%
1J Leistung:
+26.84%
1-Tages-Spanne:
$74.53
$75.42
1-Wochen-Bereich:
$73.80
$77.34
52-Wochen-Spanne:
$43.56
$77.34
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
74.84 | 94.63B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
341.95 | 312.96B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
285.07 | 75.82B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
317.51 | 71.31B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
254.32 | 30.60B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Popular healthcare retail chain files Chapter 11 bankruptcy - TheStreet
Leadership Powerhouse: ADP Taps Former CEOs of CVS Health and Intel to Join Board of Directors - Stock Titan
CVS Omnicare's Chapter 11 filing caps decade of struggles - The Business Journals
CVS Health Gains as Revenue Grows, Dividend Remains Strong - MarketBeat
CVS Health (CVS) Among PBMs Proposing Voluntary Changes to Avoid Regulation - GuruFocus
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Yahoo Finance
Public Employees Retirement System of Ohio Decreases Position in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Sets New 1-Year HighWhat's Next? - MarketBeat
CVS Health: A Deeply Undervalued Giant Investors Keep Ignoring - Seeking Alpha
CVS Moves To End Worker's Tobacco Surcharge ERISA Suit - Law360
Omnicare Can Tap $25M Initial DIP, Stage Set For Gov't Feud - Law360
Pharma middlemen propose regulatory changes to avoid Trump administration rules, Bloomberg News reports - Reuters
CVS Health (CVS) Stock Sees Minor Dip Amid Strong Yearly Performance - GuruFocus
Meet The Attys Helping CVS' Omnicare Through Ch. 11 - Law360
Aetna expanding clinical collaboration program with hospitals - Healthcare Finance News
TD Private Client Wealth LLC Raises Stake in CVS Health Corporation $CVS - MarketBeat
4,740 Shares in CVS Health Corporation $CVS Acquired by Northside Capital Management LLC - MarketBeat
Canoe Financial LP Has $111.21 Million Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Assenagon Asset Management S.A. - MarketBeat
IFM Investors Pty Ltd Acquires 10,457 Shares of CVS Health Corporation $CVS - MarketBeat
CX Institutional Grows Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Toth Financial Advisory Corp - MarketBeat
Waycross Partners LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Kingstone Capital Partners Texas LLC Acquires Shares of 2,145,239 CVS Health Corporation $CVS - MarketBeat
Park Avenue Securities LLC Boosts Stake in CVS Health Corporation $CVS - MarketBeat
Wedge Capital Management L L P NC Purchases New Shares in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Avanza Fonder AB - MarketBeat
International Private Wealth Advisors LLC Acquires New Holdings in CVS Health Corporation $CVS - MarketBeat
Why the Market Dipped But CVS Health (CVS) Gained Today - Yahoo Finance
CVS Health Ventures Leads $33.7M Series B For AmplifAI - citybiz
CVS Health subsidiary Omnicare files for Ch. 11 bankruptcy protection - San Antonio Express-News
CVS Health Subsidiary Omnicare Files For Ch. 11 Bankruptcy Protection - Barchart.com
CVS Health’s Aetna expands clinical collaboration program to enhance support for hospitals - Drug Store News
CVS’s Omnicare Files for Bankruptcy After $949 Million Judgment - MSN
CVS’s Omnicare Files Bankruptcy After $949 Million Judgment - Yahoo Finance
CVS’s Omnicare Files Bankruptcy After $949 Million Judgment (1) - Bloomberg Law News
CVS Health Drives Drug Affordability by Promoting Competition - Yahoo Finance
CVS Health (NYSE:CVS) Hits New 1-Year HighHere's Why - MarketBeat
Mn Services Vermogensbeheer B.V. Sells 3,700 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Position Increased by Swedbank AB - MarketBeat
CVS Health Corporation $CVS Stock Holdings Decreased by Alpha Omega Wealth Management LLC - MarketBeat
Procyon Advisors LLC Lowers Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Community Trust & Investment Co. - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):